Newsletter
Sign up for the Fund's newsletter and get the lastest news, calls and events
| Titel Sort descending | Periode | Program | |
|---|---|---|---|
| Eurostars 3, Call 7 - PlantScale | 2025 - 2027 | International collaborations
|
|
|
Eurostars 3, Call 7 - PlantScale
Period
2025 - 2027
Region
Program
Internationale samarbejder Area
Ikke defineret Investment
Percentage
41.71 Invested
3.7 mill. Budget
9.0 mill. Partners
ACIES BIO, biotehnološke raziskave in razvoj, d.o.o., TriptoBIO, University of Copenhagen People
TriptoBIO ApS
Read more about the project
| |||
| Eurostars 3, Call 7 - PRE-CISE | 2025 - 2026 | International collaborations
|
|
|
Eurostars 3, Call 7 - PRE-CISE
Period
2025 - 2026
Region
Program
Internationale samarbejder Area
Ikke defineret Investment
Percentage
26.2 Invested
3.8 mill. Budget
14.3 mill. Partners
Akiram Therapeutics AB, PreTT ApS, Tetrakit Technologies Aps People
Akiram Therapeutics AB
Read more about the project
| |||
| Eurostars 3, Call 7 - PROGLUNG | 2025 - 2028 | International collaborations
|
|
|
Eurostars 3, Call 7 - PROGLUNG
Period
2025 - 2028
Region
Program
Internationale samarbejder Area
Ikke defineret Investment
Percentage
52.43 Invested
2.2 mill. Budget
4.3 mill. Partners
Nordic Bioscience A/S, University Medical Center Groningen People
Nordic Bioscience
Read more about the project
| |||
| Eurostars 3, Call 7 - RE-HEAR | 2025 - 2028 | International collaborations
|
|
|
Eurostars 3, Call 7 - RE-HEAR
Period
2025 - 2028
Region
Program
Internationale samarbejder Area
Ikke defineret Investment
Percentage
15.34 Invested
2.3 mill. Budget
14.7 mill. Partners
Cilcare SAS, Teitur Trophics ApS, University of Applied Sciences and Arts Northwestern Switzerland People
Teitur Trophics
Read more about the project
| |||
| Eurostars 3, Call 7 - ReCoat | 2025 - 2027 | International collaborations
|
|
|
Eurostars 3, Call 7 - ReCoat
Period
2025 - 2027
Region
Program
Internationale samarbejder Area
Ikke defineret Investment
Percentage
43.28 Invested
2.3 mill. Budget
5.2 mill. Partners
CemeCon Scandinavia A/S, mevisco Gesellschaft für Bildverarbeitung und Visualisierung mbh & Co. Kommanditgesellschaft People
Cemecon Scandinavia A/S
Read more about the project
| |||
| Eurostars 3, Call 7 - SOLARVIS | 2025 - 2028 | International collaborations
|
|
|
Eurostars 3, Call 7 - SOLARVIS
Period
2025 - 2028
Region
Program
Internationale samarbejder Area
Ikke defineret Investment
Percentage
45.72 Invested
3.7 mill. Budget
8.2 mill. Partners
Dansk Solcelle Service, Solarzentrum Stuttgart GmbH, Technical University of Denmark People
Solarzentrum Stuttgart GmbH
Read more about the project
| |||
| Eurostars 3, Call 7 - SUPRECARB | 2025 - 2028 | International collaborations
|
|
|
Eurostars 3, Call 7 - SUPRECARB
Period
2025 - 2028
Region
Program
Internationale samarbejder Area
Ikke defineret Investment
Percentage
35.26 Invested
3.5 mill. Budget
9.9 mill. Partners
Enzidia ApS, G&G Holding AS, Teknologisk Institut, Valsemøllen af 1899 A/S People
G&G Holding AS
Read more about the project
| |||
| Eurostars 3, Call 7 - TITAN-CFRP | 2025 - 2027 | International collaborations
|
|
|
Eurostars 3, Call 7 - TITAN-CFRP
Period
2025 - 2027
Region
Program
Internationale samarbejder Area
Ikke defineret Investment
Percentage
37.61 Invested
3.7 mill. Budget
10.0 mill. Partners
Fraunhofer-Gesellschaft zur Förderung der angewandten Forschung e.V., GLAZE Technologies, Technical University of Denmark, tfc tools for composite GmbH People
GLAZE Technologies ApS
Read more about the project
| |||
| Eurostars 3, Call 8 - GOSONO | 2025 - 2027 | International collaborations
|
|
|
Eurostars 3, Call 8 - GOSONO
Period
2025 - 2027
Region
Program
Internationale samarbejder Area
Ikke defineret Investment
Percentage
49.96 Invested
3.7 mill. Budget
7.5 mill. Partners
Auricle ApS, Dreamwaves GmbH, IDUN ApS People
Auricle ApS
Read more about the project
| |||
| Eurostars 3, Call 8 - MultiLINE | 2025 - 2027 | International collaborations
|
|
|
Eurostars 3, Call 8 - MultiLINE
Period
2025 - 2027
Region
Program
Internationale samarbejder Area
Ikke defineret Investment
Percentage
30.08 Invested
3.6 mill. Budget
11.9 mill. Partners
deepeye Medical GmbH, Norlase ApS, Technical University of Denmark People
Norlase ApS
Read more about the project
| |||
| EV Array - Exosom-baseret diagnosticering af mastitis | 2019 - 2020 | Innoexplorer
|
|
|
EV Array - Exosom-baseret diagnosticering af mastitis
Period
2019 - 2020
Region
Region Nordjylland Program
Innoexplorer Area
Biotek, Medico og Sundhed Investment
Percentage
100 Invested
1.5 mill. Budget
1.5 mill. Partners
Aalborg Universitetshospital Nord People
Aalborg Universitetshospital Nord
Read more about the project
| |||
| EV-X, en pladsvenlig løsning til brand i elbiler på færger og andre svært tilgængelige områder. | 2025 - 2026 | Innofounder
|
|
|
EV-X, en pladsvenlig løsning til brand i elbiler på færger og andre svært tilgængelige områder.
Period
2025 - 2026
Region
Program
Innofounder Area
Ikke defineret Investment
Percentage
100 Invested
760.000 Budget
760.000 Klimakrisen kræver øjeblikkelige og drastiske handlinger for at opnå en bæredygtig fremtid. Overgangen til elbiler er afgørende for at reducere CO2-udledningen, og ifølge EU’s fit-for-55-act, skal alle nye køretøjer i EU være CO2-neutrale inden 2035. Elbilers batterier udgør dog en brandteknisk udfordring. Når litium-ion-batterier brænder, frigives ilt, hvilket gør brandene vanskelige at slukke og indebærer risiko for genantændelse i op til 48 timer. Derudover kræver slukning op til 40 gange mere vand end konventionelle bilbrande.
EV-X er en kompakt løsning til kompakte miljøer, der indkapsler og køler elbiler med vand, hvilket forhindrer genantændelse og muliggør sikker fjernelse af bilen. Løsningen er baseret på en innovativ indkapslende barriere, der fyldes med vand for at køle og kontrollere branden, da Dansk Brand - og Sikringsteknisk Instituts (DBI), rapport om slukning af elbiler til søs (ELBAS), peger på netop denne metode, som den mest effektive.
EV-X er en naturlig del af den grønne omstilling, den beskytter kritisk infrastruktur og skaber tryghed for passagerer og besætning på færger.
Med bevillingen fra Innofounder kan vi færdiggøre vores prototype, realisere vores vision og teste at den fungerer forsvarligt ved et certificeret brandteknisk institut.
Partners
EVstinguish ApS People
EVstinguish ApS
Read more about the project
| |||
| EVA Evidence in an AI age | 2025 - 2026 | Grand Solutions
|
|
|
EVA Evidence in an AI age
Period
2025 - 2026
Region
Program
Grand Solutions Area
Ikke defineret Investment
Percentage
72.59 Invested
12.1 mill. Budget
16.7 mill. Partners
Anders Søgaard, FERRING PHARMACEUTICALS A/S, Ghent University, Kiox Pharmaceuticals ApS, Medicinrådet, Roche Pharmaceuticals A/S, RUD PEDERSEN A/S, Silvi.ai ApS, UCB NORDIC A/S, University of Southern Denmark People
Silvi.ai ApS
Read more about the project
| |||
| Evaluation of an immune modulating cancer vaccine targeting Arginase | 2019 - 2022 | Industrial Researcher
|
|
|
Evaluation of an immune modulating cancer vaccine targeting Arginase
Period
2019 - 2022
Region
Program
Erhvervsforsker Area
Biotek, Medico og Sundhed Investment
Percentage
66.24 Invested
1.2 mill. Budget
1.9 mill. Partners
IO Biotech People
IO Biotech
Read more about the project
| |||
| Evaluation of lung tissue turnover in response to anti-fibrotic treatments of idiopathic pulmonary fibrosis | 2018 - 2021 | Industrial Researcher
|
|
|
Evaluation of lung tissue turnover in response to anti-fibrotic treatments of idiopathic pulmonary fibrosis
Period
2018 - 2021
Region
Region Hovedstaden Program
Erhvervsforsker Area
Biotek, Medico og Sundhed Investment
Percentage
47.64 Invested
1.1 mill. Budget
2.3 mill. Partners
University of Copenhagen, NORDIC BIOSCIENCE A/S People
NORDIC BIOSCIENCE A/S
Read more about the project
| |||